Answer a few quick questions about your symptoms and goals
A category may be displayed in the search results based on the similarities in the names of some Substances and Methods
This offers several potential benefits: Avoids first-pass metabolism : Unlike swallowed medications that must pass through the liver, sublingual absorption delivers drugs directly to the bloodstream Bypasses stomach acid : GLP-1 peptides are degraded by digestive enzymes, so avoiding the stomach could improve stability Rich vascular network : The area under the tongue has extensive blood vessels that allow rapid absorption However, research on peptide delivery through oral mucosa reveals significant challenges: Peptides like semaglutide and tirzepatide have molecular weights around 4000 Da (compounds above 500 Da generally show poor permeability) Salivary and mucosal proteases degrade peptides before they can cross the epithelial barrier Continuous saliva production dilutes and washes away the medication Studies with insulin showed only 1-2% bioavailability via buccal/sublingual routes without absorption enhancers The key question: Do compounded ODT formulations overcome these barriers
Exclusion of Other Causes: Medical records and testimony are often used to rule out other potential causes of the patients gastrointestinal condition
Energy: Good to excellent
Table of Contents Understanding Oral GLP-1 Medications in Clinical Practice Comparing GLP-1 Pills and Injectable Regimens Counseling, Adherence, and Monitoring Considerations Anticipating Side Effects and Clinical Outcomes FAQ Understanding Oral GLP-1 Medications in Clinical Practice In practice, oral GLP-1 therapy currently centers on semaglutide tablets
